Bausch + Lomb (BLCO) News Today → Top 5 AI Stocks to Buy for 2024 (From Market Moving Trends) (Ad) Free BLCO Stock Alerts $15.32 -0.16 (-1.03%) (As of 06/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 3, 2024 | marketbeat.comShort Interest in Bausch + Lomb Co. (NYSE:BLCO) Increases By 5.6%Bausch + Lomb Co. (NYSE:BLCO - Get Free Report) saw a large increase in short interest in May. As of May 15th, there was short interest totalling 1,880,000 shares, an increase of 5.6% from the April 30th total of 1,780,000 shares. Currently, 4.9% of the shares of the stock are sold short. Based on an average daily trading volume, of 475,000 shares, the days-to-cover ratio is currently 4.0 days.June 3, 2024 | businesswire.comBausch + Lomb Launches Blink™ NutriTears® Clinically Proven Nutritional Supplement for Dry Eyes in the United StatesMay 29, 2024 | finance.yahoo.comBausch + Lomb Announces 2024 Annual Meeting of Shareholder ResultsMay 29, 2024 | businesswire.comBausch + Lomb Announces 2024 Annual Meeting of Shareholder ResultsMay 28, 2024 | finance.yahoo.comBausch + Lomb Announces Presentation of New Scientific Data and Evaluations Featuring Consumer, Vision Care and Pharmaceutical Products at Optometry’s Meeting®May 28, 2024 | businesswire.comBausch + Lomb Receives Health Canada Approval for enVista® Envy™* Full Visual Range Intraocular LensMay 28, 2024 | markets.businessinsider.comBausch + Lomb: Strong Sales and Market Share Growth Justify Buy RatingMay 25, 2024 | marketbeat.comBausch + Lomb Co. (NYSE:BLCO) Given Average Rating of "Moderate Buy" by BrokeragesBausch + Lomb Co. (NYSE:BLCO - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the eleven brokerages that are currently covering the stock, MarketBeat.com reports. Five equities research analysts have rated the stock with a hold recommendation and six have issued aMay 24, 2024 | seekingalpha.comBausch + Lomb's Bet-The-Farm Xiidra Acquisition Is Looking Questionable, But Miebo Could Make The Stock A WinnerMay 22, 2024 | seekingalpha.comBausch + Lomb Corporation: Spin-Off Ready To Fly Troubled Nest And Find UpsideMay 21, 2024 | uk.finance.yahoo.comBHC May 2024 7.000 putMay 21, 2024 | uk.finance.yahoo.comBHC Sep 2024 4.000 callMay 21, 2024 | theglobeandmail.comClosing Bell: Bausch Lomb Corporation flat on Tuesday (BLCO)May 20, 2024 | markets.businessinsider.comStrong Performance and Positive Outlook for Bausch + Lomb Corporation Affirm Buy RatingMay 16, 2024 | marketbeat.comJump Financial LLC Raises Position in Bausch + Lomb Co. (NYSE:BLCO)Jump Financial LLC increased its holdings in Bausch + Lomb Co. (NYSE:BLCO - Free Report) by 478.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 87,100 shares of the company's stock after purchasing aMay 7, 2024 | msn.comMorgan Stanley Upgrades Bausch + Lomb (BLCO)May 6, 2024 | marketbeat.comBausch + Lomb (NYSE:BLCO) Shares Gap Up to $13.60Bausch + Lomb (NYSE:BLCO) Shares Gap Up to $13.60May 6, 2024 | msn.comMorgan Stanley upgrades Bausch + Lomb, cites improving marginsMay 6, 2024 | marketbeat.comBausch + Lomb (NYSE:BLCO) Upgraded to Overweight at Morgan StanleyMorgan Stanley raised Bausch + Lomb from an "equal weight" rating to an "overweight" rating and increased their price objective for the stock from $16.00 to $18.00 in a research note on Monday.May 4, 2024 | theglobeandmail.comBausch & Lomb: Top 10 Undervalued Growth Stocks on TSX (BLCO)May 3, 2024 | marketbeat.comQ2 2024 Earnings Forecast for Bausch + Lomb Co. Issued By HC Wainwright (NYSE:BLCO)Bausch + Lomb Co. (NYSE:BLCO - Free Report) - Stock analysts at HC Wainwright lifted their Q2 2024 EPS estimates for shares of Bausch + Lomb in a report issued on Thursday, May 2nd. HC Wainwright analyst Y. Chen now expects that the company will post earnings of $0.20 per share for the quarter, uMay 3, 2024 | finance.yahoo.comBausch + Lomb First Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsMay 3, 2024 | msn.comBausch + Lomb recalls Project Watson dog eye wipes due to risk of bacteria, fungus exposureMay 3, 2024 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Bausch + Lomb Corporation (BLCO), 10x Genomics (TXG) and LivaNova (LIVN)May 2, 2024 | markets.businessinsider.comRobust Start and Organic Growth Affirm Bausch + Lomb’s Buy RatingMay 2, 2024 | markets.businessinsider.comBuy Rating Affirmed for Bausch + Lomb: Strong Q1 Performance and Promising Growth Outlook Despite FX HeadwindsMay 2, 2024 | marketbeat.comBausch + Lomb (NYSE:BLCO) PT Lowered to $15.00 at EvercoreEvercore cut their target price on shares of Bausch + Lomb from $17.00 to $15.00 and set an "in-line" rating for the company in a research note on Thursday.May 2, 2024 | marketbeat.comBausch + Lomb (NYSE:BLCO) Hits New 1-Year Low After Earnings MissBausch + Lomb (NYSE:BLCO) Reaches New 52-Week Low on Disappointing EarningsMay 2, 2024 | marketbeat.comBausch + Lomb (NYSE:BLCO) Posts Earnings Results, Misses Expectations By $0.02 EPSBausch + Lomb (NYSE:BLCO - Get Free Report) announced its quarterly earnings data on Wednesday. The company reported $0.07 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.09 by ($0.02). Bausch + Lomb had a positive return on equity of 3.70% and a negative net margin of 6.27%. The company had revenue of $1.10 billion for the quarter, compared to the consensus estimate of $1.06 billion. During the same quarter in the prior year, the company earned $0.10 EPS. The company's revenue for the quarter was up 18.0% on a year-over-year basis.May 2, 2024 | marketbeat.comBausch + Lomb (NYSE:BLCO) Stock Rating Reaffirmed by HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $20.00 target price on shares of Bausch + Lomb in a research note on Thursday.May 2, 2024 | gurufocus.comQ1 2024 Bausch + Lomb Corp Earnings Call TranscriptMay 1, 2024 | marketwatch.comBausch + Lomb Quarterly Loss WidensMay 1, 2024 | businesswire.comBausch + Lomb Announces First-Quarter 2024 ResultsApril 30, 2024 | marketbeat.comShort Interest in Bausch + Lomb Co. (NYSE:BLCO) Expands By 8.7%Bausch + Lomb Co. (NYSE:BLCO - Get Free Report) saw a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 1,630,000 shares, an increase of 8.7% from the March 31st total of 1,500,000 shares. Based on an average daily trading volume, of 464,700 shares, the days-to-cover ratio is currently 3.5 days. Approximately 4.3% of the shares of the company are short sold.April 30, 2024 | msn.comBausch + Lomb Q1 2024 Earnings PreviewApril 30, 2024 | marketbeat.comBausch + Lomb Co. (NYSE:BLCO) Given Consensus Recommendation of "Moderate Buy" by BrokeragesBausch + Lomb Co. (NYSE:BLCO - Get Free Report) has earned an average recommendation of "Moderate Buy" from the ten brokerages that are covering the company, Marketbeat.com reports. Five equities research analysts have rated the stock with a hold rating and five have issued a buy rating on the coApril 29, 2024 | businesswire.comBausch + Lomb Announces Presentation of New Data at the Association for Research in Vision and Ophthalmology Annual MeetingApril 25, 2024 | msn.comBausch + Lomb reports positive study results for Blink NutriTearsApril 25, 2024 | businesswire.comBausch + Lomb Announces Statistically Significant Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry EyesApril 22, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Bausch + Lomb Corporation (BLCO), Edgewise Therapeutics (EWTX)April 22, 2024 | marketbeat.comRoyal Bank of Canada Cuts Bausch + Lomb (NYSE:BLCO) Price Target to $18.00Royal Bank of Canada cut their target price on Bausch + Lomb from $20.00 to $18.00 and set an "outperform" rating on the stock in a research note on Monday.April 18, 2024 | finance.yahoo.comBausch + Lomb Corporation (BLCO)April 18, 2024 | businesswire.comBausch + Lomb Reports More Than 84 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through Innovative Recycling ProgramsApril 17, 2024 | marketbeat.comBausch + Lomb Co. (NYSE:BLCO) Shares Purchased by River Road Asset Management LLCRiver Road Asset Management LLC boosted its holdings in Bausch + Lomb Co. (NYSE:BLCO - Free Report) by 21.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,938,207 shares of the company's stock aApril 15, 2024 | businesswire.comBausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1April 11, 2024 | msn.comBausch Health gains after appeals court affirms ruling in Norwich patent case (update)April 11, 2024 | marketbeat.comBausch + Lomb (NYSE:BLCO) Sees Unusually-High Trading VolumeBausch + Lomb (NYSE:BLCO) Sees Unusually-High Trading VolumeApril 9, 2024 | markets.businessinsider.comBausch + Lomb’s Strong Market Position and Innovative Pipeline Justify Buy RatingApril 4, 2024 | marketbeat.comBausch + Lomb (NYSE:BLCO) PT Raised to $17.00 at Evercore ISIEvercore ISI boosted their target price on Bausch + Lomb from $16.50 to $17.00 and gave the stock an "in-line" rating in a report on Thursday.April 2, 2024 | markets.businessinsider.comBausch + Lomb’s Strong Position in Dry Eye Market Prompts Buy Rating Get Bausch + Lomb News Delivered to You Automatically Sign up to receive the latest news and ratings for BLCO and its competitors with MarketBeat's FREE daily newsletter. Email Address Millionaire-Making “Wealth Pattern” Just Repeated on April 22 (Ad)If you think you missed out on the Bitcoin band wagon… You need to watch this immediately. This Crypto bull market is not even halfway over BLCO Media Mentions By Week BLCO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BLCO News Sentiment▼0.970.73▲Average Medical News Sentiment BLCO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BLCO Articles This Week▼23▲BLCO Articles Average Week Get Bausch + Lomb News Delivered to You Automatically Sign up to receive the latest news and ratings for BLCO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Cooper Companies News Today RxSight News Today STAAR Surgical News Today Warby Parker News Today National Vision News Today Innovative Eyewear News Today Alcon News Today Align Technology News Today Teva Pharmaceutical Industries News Today Alnylam Pharmaceuticals News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BLCO) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersMillionaire-Making “Wealth Pattern” Just Repeated on April 22If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI Hell Will Break Loose [June 30, 2024] …On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...Banyan Hill Publishing | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | Sponsored